U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry EPIMERIC
Molecular Formula C21H22N6O2
Molecular Weight 390.4384
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLASDEGIB N-OXIDE

SMILES

C[N+]1([O-])CC[C@H](C[C@@H]1C2=NC3=C(N2)C=CC=C3)NC(=O)NC4=CC=C(C=C4)C#N

InChI

InChIKey=VRZGUODKSBGINI-MQERFVCMSA-N
InChI=1S/C21H22N6O2/c1-27(29)11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H,25,26)(H2,23,24,28)/t16-,19-,27?/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H22N6O2
Molecular Weight 390.4384
Charge 0
Count
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 2 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 04:20:21 GMT 2025
Edited
by admin
on Wed Apr 02 04:20:21 GMT 2025
Record UNII
MX88GLV6JK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLASDEGIB N-OXIDE
Common Name English
GLASDEGIB METABOLITE M4
Preferred Name English
UREA, N-((2R,4R)-2-(1H-BENZIMIDAZOL-2-YL)-1-METHYL-1-OXIDO-4-PIPERIDINYL)-N'-(4-CYANOPHENYL)-
Systematic Name English
1-((2R,4R)-2-(1H-BENZIMIDAZOL-2-YL)-1-METHYL-1-OXIDO-PIPERIDIN-1-IUM-4-YL)-3-(4-CYANOPHENYL)UREA
Systematic Name English
Code System Code Type Description
FDA UNII
MX88GLV6JK
Created by admin on Wed Apr 02 04:20:21 GMT 2025 , Edited by admin on Wed Apr 02 04:20:21 GMT 2025
PRIMARY
PUBCHEM
155884436
Created by admin on Wed Apr 02 04:20:21 GMT 2025 , Edited by admin on Wed Apr 02 04:20:21 GMT 2025
PRIMARY
CAS
2222533-67-5
Created by admin on Wed Apr 02 04:20:21 GMT 2025 , Edited by admin on Wed Apr 02 04:20:21 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Glasdegib was the most abundant circulating component in plasma, constituting 69% of plasma radioactivity, with minor circulating metabolites each being <8% of radioactivity.